Gulfo Adele M. 4
4 · NewAmsterdam Pharma Co N.V. · Filed Apr 17, 2025
Insider Transaction Report
Form 4
Gulfo Adele M.
Director
Transactions
- Award
Ordinary Shares
2025-04-15+10,860→ 10,860 total - Award
Option (right to buy)
2025-04-15+50,700→ 50,700 totalExercise: $16.06Exp: 2035-04-15→ Ordinary Shares (50,700 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
- [F2]Each RSU was granted on April 15, 2025 for no consideration.
- [F3]33% of the shares underlying the option will vest on April 15, 2026, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.